All News

Chemotherapy treatment can lead to bacterial changes in the gut and unhealthy weight gain for patients, with potential higher risk of morbidity and reduced quality of life, according to recent research.

Advancements have been made over the last decade in the use of immunotherapy for the treatment of skin cancers including melanoma, squamous cell carcinoma and Merkel cell carcinoma.

Sometimes difficult experiences like cancer can come with blessings in disguise.

Multiple considerations must be made when determining cancer treatment regimens amid the ongoing chemotherapy shortage, explained an oncologist.

Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too.

Patients with a subset of acute myeloid leukemia may have improved survival rates and lower risk of relapse with Nexavar maintenance.

I am so happy that I was able to celebrate my wedding anniversary with my biggest supporter.

Adding Keytruda to chemoradiotherapy significantly improved progression-free survival for patients with newly diagnosed high-risk locally advanced cervical cancer.

Even with the increase of immunotherapy utilization to treat patients with advanced renal cell carcinoma, more research is needed to determine in which order to administer it as later lines of therapy.

As Jill Biden helps to heighten Medicare for cancer patients, 15-year old swimmer raises money for Swim Across America and Carlos Carrasco furthers his program, “Cookie’s Kids,” this is what is happening in the oncology space this week.

The Food and Drug Administration approved a Vanflyta regimen for patients with FLT-ITD—positive acute myeloid leukemia.

Frontline Zejula maintenance therapy decreased the risk of disease progression or death in patients with newly diagnosed ovarian cancer.

Cost burdens are prevalent among patients with metastatic prostate cancer; however, utilizing appropriate resources could reduce costs up to 100%.

The treatment combination of Rybrevant and chemotherapy significantly improved progression-free survival rates for patients newly diagnosed with metastatic NSCLC with EGFR Exon 20 insertion mutations.

After recovering from a bone marrow transplant to tackle a recurrence of acute myeloid leukemia, I started to volunteer.

Rivoceranib plus Airuika demonstrates improvement for survival in patients with unresectable hepatocellular carcinoma, a subset of liver cancer.

Therapies that target specific characteristics on kidney cancer cells are showing promise in the space, an expert explained.

Patients with MPNs can potentially experience long asymptomatic periods, and it’s up to patients and providers to remain vigilant as they monitor and manage symptoms.

Having a strong connection with their care team can be crucial for the well-being of LGBTQ+ patients with cancer, as a colorectal cancer survivor and surgeon from City of Hope told CURE®.

Most of us dread, simply dread, hearing the words, “I’m sorry you have cancer.” I did.

With new treatments being explored, it’s an exciting time for patients with kidney cancer, an expert explained.

An expert explained what aspects of a patient’s disease cancer care teams use to determine the best treatment options for patients with clear cell renal cell carcinoma.

This particular designation may expedite the process of approving Xpovio for the treatment of patients with myelofibrosis to address an unmet medical need.

Implementing longer intervals between the completion of neoadjuvant therapy and surgery may have a positive effect on pathologic complete responses for patients with locally advanced rectal cancer.

Even though I did smoke cigarettes, I made sure that I didn't smoke enough to get cancer from it.

Patients with BAP1-mutated renal cell carcinoma who were treated with Lynparza obtained responses with favorable side effect profiles.

A recent study has determined that Xospata plus chemo is safe for the treatment of relapsed/refractory acute myeloid leukemia with an FLT3 mutation.

A patient with glioblastoma, a type of brain cancer, was dosed with a novel combination immunotherapy as part of a phase 2b trial.